NBPBX
Price
$46.20
Change
-$0.52 (-1.11%)
Updated
Sep 6 closing price
VVIAX
Price
$65.30
Change
-$0.84 (-1.27%)
Updated
Sep 6 closing price
Ad is loading...

NBPBX vs VVIAX

Header iconNBPBX vs VVIAX Comparison
Open Charts NBPBX vs VVIAXBanner chart's image
Neuberger Berman Large Cap Value Adv
Price$46.20
Change-$0.52 (-1.11%)
VolumeN/A
CapitalizationN/A
Vanguard Value Index Adm
Price$65.30
Change-$0.84 (-1.27%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
NBPBX vs VVIAX Comparison Chart
Loading...
VS
NBPBX vs. VVIAX commentary
Sep 08, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NBPBX is a Buy and VVIAX is a Buy.

FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 183B vs. NBPBX (9.06B). VVIAX pays higher dividends than NBPBX: VVIAX (2.36) vs NBPBX (1.95). NBPBX was incepted earlier than VVIAX: NBPBX (28 years) vs VVIAX (24 years). NBPBX is a more actively managed with annual turnover of: 81.00 vs. VVIAX (10.00). NBPBX has a lower initial minimum investment than VVIAX: NBPBX (0) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 19.30 vs. NBPBX (13.85). NBPBX return over 5 years is better than : 60.37 vs. VVIAX (53.51).
NBPBXVVIAXNBPBX / VVIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence28 years24 years-
Gain YTD12.74113.50694%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets9.06B183B5%
Annual Yield % from dividends1.952.3683%
Returns for 1 year13.8519.3072%
Returns for 3 years8.7819.6845%
Returns for 5 years60.3753.51113%
Returns for 10 years19.74107.5718%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GDYN14.080.47
+3.45%
Grid Dynamics Holdings
USEG0.910.01
+1.00%
US Energy Corp
BCE35.950.07
+0.20%
BCE
LNKB6.15N/A
N/A
LINKBANCORP
CRNX50.98-1.82
-3.45%
Crinetics Pharmaceuticals